Applying Precision Medicine in Choosing an Anti-obesity Medication: A case-based approach (Masters Track)
There is a marked variation in individual patient response to interventions designed to treat obesity and adiposity related diseases. The heterogenicity in obesity treatment response is not surprising when considering the numerous underlying factors that contribute to adiposity and associated conditions. This session will use case presentations to demonstrate how identifying patient phenotypic subgroups when choosing an anti-obesity agent, can improve clinical outcomes in patients treated for obesity.
Recorded during Obesity Medicine 2022.
CME/CE Expiration Date: 5/1/25
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
Andres Acosta, MD, PhD, DABOM
Dominique Williams, MD, MPH, FAAP, ABOM
The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Obesity Medicine Association designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.25 AMA PRA Category 1 Credit™The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Obesity Medicine Association designates this Enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity.